Bg pattern

APREPITANT QILU 125 mg HARD CAPSULES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use APREPITANT QILU 125 mg HARD CAPSULES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Aprepitant Qilu 125 mg hard capsules EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Aprepitant Qilu and what is it used for
  2. What you need to know before you take Aprepitant Qilu
  3. How to take Aprepitant Qilu
  4. Possible side effects
  5. Storage of Aprepitant Qilu
  6. Contents of the pack and other information

1. What is Aprepitant Qilu and what is it used for

This medicine contains the active substance aprepitant and belongs to a group of medicines called "neurokinin 1 (NK1) receptor antagonists". The brain has a specific area that controls nausea and vomiting. Aprepitant works by blocking the signals in this area, and thus reducing nausea and vomiting. Aprepitant capsules are used in adults and adolescents from 12 years of age, in combination with other medicinesto prevent nausea and vomiting caused by cancer chemotherapy (that induces strong and moderate nausea and vomiting, such as cisplatin, cyclophosphamide, doxorubicin, or epirubicin).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Aprepitant Qilu

Do not take Aprepitant Qilu

  • if you are allergic to aprepitant or any of the other ingredients of this medicine (listed in section 6).
  • with medicines that contain pimozide (used to treat psychiatric disorders), terfenadine, and astemizole (used for allergic rhinitis and other allergic disorders), cisapride (used to treat digestive problems). Inform your doctor if you are taking these medicines, as treatment should be modified before starting aprepitant.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting this medicine.

Before treatment with this medicine, inform your doctor if you have liver disease, as the liver is important for removing the medicine from the body. Therefore, your doctor may need to monitor your liver condition.

Children and adolescents

Do not give this medicine to children under 12 years of age, as 125 mg capsules have not been studied in this population.

Other medicines and Aprepitant Qilu

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Aprepitant may affect other medicines during and after treatment with aprepitant. There are some medicines that should not be taken with aprepitant (such as pimozide, terfenadine, astemizole, and cisapride) or that require a dose adjustment (see also ‘Do not take Aprepitant Qilu’).

The effects of aprepitant or other medicines may be influenced if you take aprepitant with other medicines, including those listed below. Consult your doctor or pharmacist if you are taking any of the following medicines:

  • contraceptive medicines that may include birth control pills, skin patches, implants, and certain intrauterine devices (IUDs) that release hormones; they may not work properly when taken with this medicine. During treatment with this medicine and up to 2 months after using aprepitant.
  • cyclosporine, tacrolimus, sirolimus, everolimus (immunosuppressants used to prevent organ rejection after a transplant);
  • alfentanil, fentanyl (used to treat pain);
  • quinidine (used to treat irregular heartbeats);
  • irinotecan, etoposide, vinorelbine, ifosfamide (cancer medicines);
  • medicines that contain ergot-derived alkaloids, such as ergotamine or dihydroergotamine (used to treat migraines);
  • warfarin, acenocoumarol (blood thinners; blood tests may be needed);
  • rifampicin, clarithromycin, telithromycin (antibiotics used to treat infections);
  • phenytoin (used to treat seizures);
  • carbamazepine (used to treat depression and epilepsy);
  • midazolam, triazolam, phenobarbital (medicines used to calm or help sleep);
  • St. John's Wort (a herbal preparation used to treat depression);
  • protease inhibitors (used to treat HIV infections);
  • ketoconazole, except shampoo (used to treat Cushing's syndrome - when the body produces too much cortisol);
  • itraconazole, voriconazole, posaconazole (used to treat fungal infections);
  • nefazodone (used to treat depression);
  • corticosteroids (such as dexamethasone and methylprednisolone);
  • anxiety medicines (such as alprazolam);
  • tolbutamide (used to treat diabetes).

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.

This medicine should not be used during pregnancy unless strictly necessary.

For information on birth control, see ‘Using Aprepitant Qilu with other medicines’.

It is not known if this medicine is excreted in breast milk; therefore, breastfeeding should not be done during treatment with this medicine. It is important to inform your doctor before starting this medicine if you are breastfeeding or plan to do so.

Driving and using machines

It should be taken into account that some people have dizziness and drowsiness after taking this medicine. If you feel dizzy or drowsy, avoid driving, cycling, or using machines or tools after taking this medicine (see ‘Possible side effects’).

Aprepitant Qilu contains sucrose

This medicine contains sucrose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

Aprepitant Qilu contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per capsule; this is essentially ‘sodium-free’.

3. How to take Aprepitant Qilu

Always take this medicine exactly as your doctor, pharmacist, or nurse has told you. If you are not sure, check with your doctor, pharmacist, or nurse.

Take aprepitant always with other medicines to prevent nausea and vomiting. After treatment with this medicine, your doctor may ask you to continue taking other medicines to prevent nausea and vomiting, including corticosteroids (such as dexamethasone) and a ‘5-HT3 antagonist’ (such as ondansetron).

The recommended oral dose of this medicine is:

Day 1:

  • one 125 mg capsule 1 hour before starting the chemotherapy session.

and

Days 2 and 3:

  • one 80 mg capsule each day.

Aprepitant can be taken with or without food.

Swallow the capsule whole with some liquid.

If you take more Aprepitant Qilu than you should

Do not take more capsules than your doctor recommends. If you have taken too many capsules, contact your doctor immediately.

If you forget to take Aprepitant Qilu

If you miss a dose, consult your doctor.

If you have any further questions on the use of this product, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking this medicine and contact your doctor immediately if you notice any of the following serious side effects, which may require urgent medical attention:

Frequency not known (cannot be estimated from the available data)

  • Hives, rash, itching, difficulty breathing or swallowing; these are signs of an allergic reaction.

Other side effects that have been reported are listed below.

Common (may affect up to 1 in 10 people):

  • constipation, indigestion
  • headache
  • fatigue
  • loss of appetite
  • hiccups
  • increase in liver enzymes in the blood.

Uncommon (may affect up to 1 in 100 people):

  • dizziness, drowsiness
  • acne, rash
  • anxiety
  • belching, nausea, vomiting, heartburn, stomach pain, dry mouth, flatulence
  • increased painful or burning urination
  • weakness, general feeling of being unwell
  • flushing or redness of the face or skin
  • rapid or irregular heartbeat
  • fever with a high risk of infection, decrease in red blood cells.

Rare (may affect up to 1 in 1,000 people):

  • difficulty thinking, lack of energy, altered taste
  • skin sensitivity to sunlight, excessive sweating, oily skin, skin ulcers, itchy rash, Stevens-Johnson syndrome/toxic epidermal necrolysis (rare severe skin reactions)
  • euphoria (extreme feeling of happiness), disorientation
  • bacterial infection, fungal infection
  • severe constipation, stomach ulcers, inflammation of the small intestine and colon, mouth ulcers, abdominal distension
  • frequent urination, urinating more than usual, presence of sugar or blood in the urine
  • chest discomfort, swelling, changes in walking
  • cough, mucous in the back of the throat, throat irritation, sneezing, sore throat
  • eye discharge or itching
  • ringing in the ears
  • muscle spasms, muscle weakness
  • excessive thirst
  • slow heartbeat, blood vessel and vein problems
  • decrease in white blood cells, low sodium levels in the blood, weight loss.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Vigilance System for Human Use: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Aprepitant Qilu

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month.

This medicine does not require any special storage conditions.

Store in the original package to protect from moisture.

Do not remove the capsule from the blister until the moment of intake.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Aprepitant Qilu

  • The active substance is aprepitant. Each 125 mg hard capsule contains 125 mg of aprepitant.
  • The other ingredients are: hypromellose, sodium lauryl sulfate, sucrose (see section 2, “Aprepitant Qilu contains sucrose”), microcrystalline cellulose, talc, gelatin, titanium dioxide (E 171), red iron oxide (E 172), lacquer, potassium hydroxide, black iron oxide (E 172).

Appearance and packaging

The 125 mg hard capsule is a size 1 opaque capsule with a white body and a pink cap with “30” and “125 mg” printed radially in black ink on the body.

Aprepitant 125 mg hard capsules are available in the following pack sizes:

  • 1 aluminum blister containing one 125 mg capsule.
  • 5 aluminum blisters, each containing one 125 mg capsule.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

QILU PHARMA SPAIN S.L.

Paseo De La Castellana 40

8th floor, 28046 - Madrid

Spain

Manufacturer

KYMOS, S.L.

Ronda de Can Fatjó 7b, Parc Tecnológic el Vallès

Cerdanyola del Vallès, 08290,

Spain

Netpharmalab consulting services

Carretera de Fuencarral 22

Alcobendas, 28108 Madrid

Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

ES (RMS)

Aprepitant Qilu 125 mg hard capsules EFG

DE

Aprepitant Qilu 125 mg Hartkapseln

FR

Aprepitant Qilu 125 mg gélules

IT

Aprepitant Qilu

Date of last revision of this leaflet:September 2020.

Other sources of information

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for APREPITANT QILU 125 mg HARD CAPSULES

Discuss questions about APREPITANT QILU 125 mg HARD CAPSULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (25)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
5.0 (764)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for APREPITANT QILU 125 mg HARD CAPSULES?
APREPITANT QILU 125 mg HARD CAPSULES requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in APREPITANT QILU 125 mg HARD CAPSULES?
The active ingredient in APREPITANT QILU 125 mg HARD CAPSULES is aprepitant. This information helps identify medicines with the same composition but different brand names.
Who manufactures APREPITANT QILU 125 mg HARD CAPSULES?
APREPITANT QILU 125 mg HARD CAPSULES is manufactured by Qilu Pharma Spain S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of APREPITANT QILU 125 mg HARD CAPSULES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether APREPITANT QILU 125 mg HARD CAPSULES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to APREPITANT QILU 125 mg HARD CAPSULES?
Other medicines with the same active substance (aprepitant) include APREPITANT ACCORD 125 mg HARD CAPSULES / APREPITANT ACCORD 80 mg HARD CAPSULES, APREPITANT QILU 125 mg HARD CAPSULES / APREPITANT QILU 80 mg HARD CAPSULES - Generic, APREPITANT QILU 80 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media